Invention Grant
- Patent Title: Sodium channel blockers
-
Application No.: US15526431Application Date: 2016-02-11
-
Publication No.: US10590078B2Publication Date: 2020-03-17
- Inventor: Ji Duck Kim , Hyung Geun Lee , Inwoo Kim , Sun Ah Jun , Myunggi Jung , Hyo Shin Kim
- Applicant: Daewoong Pharmaceutical Co., Ltd.
- Applicant Address: KR Gyeonggi-do
- Assignee: Daewoong Pharmaceutical Co., Ltd.
- Current Assignee: Daewoong Pharmaceutical Co., Ltd.
- Current Assignee Address: KR Gyeonggi-do
- Agency: Marshall, Gerstein & Borun LLP
- Priority: KR10-2015-0021160 20150211
- International Application: PCT/KR2016/001395 WO 20160211
- International Announcement: WO2016/129933 WO 20160818
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K31/416 ; A61K31/4439 ; C07D209/10 ; C07D231/56 ; C07D401/04 ; C07D401/06 ; C07D403/04 ; C07D403/10 ; C07D417/04 ; C07D417/12 ; C07D417/14 ; C07D471/04 ; C07D403/12 ; C07D209/30 ; C07D209/42 ; C07D401/12

Abstract:
The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and use thereof. The compound represented by the Formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof can be effectively used in the prevention or treatment of pains, for example, acute pain, chronic pain, pain from nervous disease, postoperative pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, paroxysmal extreme pain disorder (PEPD).
Public/Granted literature
- US20180297948A1 SODIUM CHANNEL BLOCKERS Public/Granted day:2018-10-18
Information query
IPC分类: